Pulmonary dysfunction is a common side effect of some pediatric cancer treatments, such as chest radiotherapy. Experts discuss current screening guidelines and comment on emerging research.
Clinical trials of TRIKAFTA demonstrated robust improvement in pulmonary function in patients with cystic fibrosis. In this article, pediatric pulmonologist Nathan Kraynack, MD, shares his early experience with the new, game-changing regimen.
Our multidisciplinary team treats local patients as well as CF patients from all over the world with difficult-to-treat infections.
The director of Cleveland Clinic Children’s cystic fibrosis program opines on the merits and pitfalls of newborn screening, when to refer and the benefits of teaming with adult-care specialists.